搜尋結果
Levodropropizine. This information is not country-specific. Please refer to the Hong Kong prescribing information. Generic Medicine Info. Indications and Dosage. Oral. Cough. Adult: 60 mg up to tid at intervals of at least 6 hours. Dosage recommendations may vary among countries or individual products (refer to specific product guidelines).
special reports. In an interview with MIMS Doctor, Dr Ka-Yuen Lock, Specialist in Endocrinology, Diabetes and Metabolism in Hong Kong, discussed management of diabetes mellitus (DM), including use of ultra-long-acting insulin, in optimizing glycaemic control. She also shared a case study illustrating improvements in glucose variability and ...
Daflon Dosage & Drug Information | MIMS Hong Kong. MIMS home. Drugs. Info. Daflon達夫隆. diosmin + hesperidin. / Concise Prescribing Info. Contents. Micronized purified flavonoid fraction: Per 500 mg FC tab Diosmin 450 mg, flavonoids expressed as hesperidin 50 mg. Per 1,000 mg FC tab Diosmin 900 mg, flavonoids expressed as hesperidin 100 mg.
Brolucizumab. Indications/Uses. Neovascular (wet) age-related macular degeneration (AMD) in adults. Visual impairment due to diabetic macular oedema (DME) in adults. Click to view Beovu detailed prescribing information. Dosage/Direction for Use.
Skyrizi Dosage & Drug Information | MIMS Hong Kong. Skyrizi喜開悅. risankizumab. / Concise Prescribing Info. Contents. Risankizumab. Indications/Uses. Moderate to severe plaque psoriasis in adults who are candidates for systemic therapy.
MIMS home. Drugs. Info. Rowachol露化膽鈣. Concise Prescribing Info. Contents. Pinene 17 mg, camphene 5 mg, cineol 2 mg, menthone 6 mg, levomenthol 32 mg, borneol 5 mg, olive oil 33 mg. Indications/Uses. Treatment of hepatobiliary disorders including dissolution of gallstones. Click to view Rowachol detailed prescribing information.
MIMS home. Drugs. Info. Nilemdo利清脂. Concise Prescribing Info. Contents. Bempedoic acid. Indications/Uses. Adjunct to diet & maximally tolerated statin therapy for the treatment of adults w/ heterozygous familial hypercholesterolemia or established atherosclerotic CV disease who require additional lowering of LDL-C.
